Follow on Google News News By Tag * Pharmaceutical Sales * Cnpr Certification * Napsrx * Sales Marketing * Sales Representatives * More Tags... Industry News News By Place Country(s) Industry News
Follow on Google News | NAPSR news: J & J Announces Strong Second Quarter Results- Pharmaceutical Sales SoarJohnson & Johnson a proven industry leader in the healthcare sector is the first big pharma corporation to unveil the second quarter results for 2014. The pharmaceuticals division made an impressive contribution to the strong sales growth.
By: NAPSRx “Our strong second-quarter results reflect the continued success of our new product launches and the progress we have made in achieving our near-term priorities,” The Pharmaceuticals division was a key player in the significant sales boost for J & J. Worldwide pharma sales generated $8.5 billion for the second quarter and sales increased 21.1% from last year’s quarter on a total and operational basis. According to the news released issued by J & J, “Domestic sales increased 36.6%. International sales increased 6.8% which reflected an operational increase of 6.9% and a negative currency impact of 0.1%.” Strong pharmaceutical sales were fueled by new product launches which include: · OLYSIO®/SOVRIAD® · XARELTO® (rivaroxaban) · ZYTIGA® (abiraterone acetate), oral, once daily medication combined with prednisone to treat metastatic, castration-resistant prostate cancer · INVOKANA®(canagliflozin) · IMBRUVICA® (ibrutinib), - kinase inhibitor to treat mantle cell lymphoma and chronic lymphocytic leukemia in patients who have had at least one prior therapy Among J & J’s established prescription portfolio, other products that contributed to the sales growth include: · STELARA® (ustekinumab) · REMICADE® (infliximab) · INVEGA® SUSTENNA®/ · PREZISTA® (darunavir), a treatment for HIV J & J also received approval during the quarter from the U.S. Food and Drug Administration (FDA) and the European Commission (EC) for SYLVANT® (siltuximab) NOW IS THE TIME TO ENTER INTO THIS WONDERFUL FIELD! With such industry leaders posting gains in profitability, they will need both certified and qualified individuals to promote their diversified product portfolio. When industry leaders look for new candidates for sales/marketing positions, they look toward individuals that are industry trained. Companies are looking for people that have the background to market their product both proficiently and efficiently. CANDIDATES WHO WANT TO BREAK INTO PHARMACEUTICAL SALES! The CNPR is a federally trademarked certification you can earn by demonstrating the necessary knowledge in pharmacology, medical terminology, physiology, and regulations for selling pharmaceuticals. The CNPR examination is dedicated to increasing the professional level of NAPSR members and to developing meaningful and ethical standards fully accepted by both its members and members of the pharmaceutical community. The CNPR® Program represents a level of industry achievement and a demonstrated knowledge of pharmacology, medical terminology, pharmaceutical selling guidelines, physician selling techniques and industry standards. Pharmaceutical sales candidates who have this training will differentiate themselves from other individuals looking for open positions. Upon successful completion of the training each student will receive the Certification Mark of the CNPR®. CNPR® graduates should immediately utilize the NAPSRx® Career Center to apply for pharmaceutical sales positions. Individuals that are interested in becoming a Certified National Pharmaceutical Representative (CNPR) can contact the National Association of Pharmaceutical Sales Representatives( End
Account Email Address Account Phone Number Disclaimer Report Abuse Page Updated Last on: Jul 16, 2014
|
|